Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Masi

Showing results (171-180 of 213) with videos related to

Pageof 22
Sort By:
Annals of Hematology|September 1, 1996
FISH analysis for CML monitoring?M C Froncillo, L Maffei, M Cantonetti, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|June 3, 2019
Rotational radiotherapy of breast cancer with polyenergetic kilovoltage X-ray beams: An experimental and Monte Carlo phantom studyF Buonanno, A Sarno, P A De Lucia, et al.
Drugs Under Experimental and Clinical Research|January 1, 1994
The effect of gamma-linolenic acid on clinical status, red cell fatty acid composition and membrane microviscosity in infants with atopic dermatitisP L Biagi, A Bordoni, S Hrelia, et al.
Blood|December 15, 1994
Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpuraR Stasi, E Stipa, M Masi, et al.
Cancer Genetics and Cytogenetics|May 1, 1993
Incidence of chromosome abnormalities and clinical significance of karyotype in de novo acute myeloid leukemiaR Stasi, G Del Poeta, M Masi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1981
Deficiency of autologous mixed lymphocyte reactions and serum thymic factor level in Down's syndromeC Franceschi, F Licastro, M Chiricolo, et al.
Annals of Hematology|February 1, 1993
All-trans retinoic acid plus low doses of cytarabine for the treatment of "poor-risk" acute myeloid leukemiasA Venditti, R Stasi, M Masi, et al.
Leukemia|July 1, 1995
All-trans retinoic acid and low-dose cytosine arabinoside for the treatment of 'poor prognosis' acute myeloid leukemiaA Venditti, R Stasi, G Del Poeta, et al.
Leukemia|August 1, 1995
All-trans retinoic acid (ATRA) administration during pregnancy in relapsed acute promyelocytic leukemiaM D Simone, R Stasi, A Venditti, et al.
Cancer|June 15, 1996
Intensive treatment of patients age 60 years and older with de novo acute myeloid leukemia: analysis of prognostic factorsR Stasi, A Venditti, G Del Poeta, et al.
Pageof 22

Showing results (171-180 of 213) with videos related to

Sort By:
Pageof 22
Annals of Hematology|September 1, 1996
FISH analysis for CML monitoring?M C Froncillo, L Maffei, M Cantonetti, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|June 3, 2019
Rotational radiotherapy of breast cancer with polyenergetic kilovoltage X-ray beams: An experimental and Monte Carlo phantom studyF Buonanno, A Sarno, P A De Lucia, et al.
Drugs Under Experimental and Clinical Research|January 1, 1994
The effect of gamma-linolenic acid on clinical status, red cell fatty acid composition and membrane microviscosity in infants with atopic dermatitisP L Biagi, A Bordoni, S Hrelia, et al.
Blood|December 15, 1994
Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpuraR Stasi, E Stipa, M Masi, et al.
Cancer Genetics and Cytogenetics|May 1, 1993
Incidence of chromosome abnormalities and clinical significance of karyotype in de novo acute myeloid leukemiaR Stasi, G Del Poeta, M Masi, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1981
Deficiency of autologous mixed lymphocyte reactions and serum thymic factor level in Down's syndromeC Franceschi, F Licastro, M Chiricolo, et al.
Annals of Hematology|February 1, 1993
All-trans retinoic acid plus low doses of cytarabine for the treatment of "poor-risk" acute myeloid leukemiasA Venditti, R Stasi, M Masi, et al.
Leukemia|July 1, 1995
All-trans retinoic acid and low-dose cytosine arabinoside for the treatment of 'poor prognosis' acute myeloid leukemiaA Venditti, R Stasi, G Del Poeta, et al.
Leukemia|August 1, 1995
All-trans retinoic acid (ATRA) administration during pregnancy in relapsed acute promyelocytic leukemiaM D Simone, R Stasi, A Venditti, et al.
Cancer|June 15, 1996
Intensive treatment of patients age 60 years and older with de novo acute myeloid leukemia: analysis of prognostic factorsR Stasi, A Venditti, G Del Poeta, et al.
Pageof 22